TY - JOUR AU - Mocroft, A. AU - Ledergerber, B. AU - Viard, J. P. AU - Staszewski, S. AU - Murphy, M. AU - Chiesi, A. PY - 2004 DA - 2004// TI - Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group JO - J Infect Dis VL - 190 UR - https://doi.org/10.1086/425424 DO - 10.1086/425424 ID - Mocroft2004 ER - TY - JOUR AU - Katlama, C. AU - Esposito, R. AU - Gatell, J. M. AU - Goffard, J. C. AU - Grinsztejn, B. AU - Pozniak, A. PY - 2007 DA - 2007// TI - Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1 JO - AIDS VL - 21 UR - https://doi.org/10.1097/QAD.0b013e328013d9d7 DO - 10.1097/QAD.0b013e328013d9d7 ID - Katlama2007 ER - TY - JOUR AU - Renaud-Thery, F. AU - Nguimfack, B. D. AU - Vitoria, M. AU - Lee, E. AU - Graaff, P. AU - Samb, B. PY - 2007 DA - 2007// TI - Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens JO - AIDS VL - 21 UR - https://doi.org/10.1097/01.aids.0000279711.54922.f0 DO - 10.1097/01.aids.0000279711.54922.f0 ID - Renaud-Thery2007 ER - TY - JOUR AU - Wilson, L. E. AU - Gallant, J. E. PY - 2009 DA - 2009// TI - The management of treatment-experienced HIV-infected patients: new drugs and drug combinations JO - Clin Infect Dis VL - 48 UR - https://doi.org/10.1086/595701 DO - 10.1086/595701 ID - Wilson2009 ER - TY - JOUR AU - Clotet, B. AU - Bellos, N. AU - Molina, J. M. AU - Cooper, D. AU - Goffard, J. C. AU - Lazzarin, A. PY - 2007 DA - 2007// TI - Efficacy and safety of darunavir–ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials JO - Lancet VL - 369 UR - https://doi.org/10.1016/S0140-6736(07)60497-8 DO - 10.1016/S0140-6736(07)60497-8 ID - Clotet2007 ER - TY - JOUR AU - Madruga, J. V. AU - Berger, D. AU - McMurchie, M. AU - Suter, F. AU - Banhegyi, D. AU - Ruxrungtham, K. PY - 2007 DA - 2007// TI - Efficacy and safety of darunavir–ritonavir compared with that of lopinavir–ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial JO - Lancet VL - 370 UR - https://doi.org/10.1016/S0140-6736(07)61049-6 DO - 10.1016/S0140-6736(07)61049-6 ID - Madruga2007 ER - TY - JOUR AU - Young, J. AU - Scherrer, A. U. AU - Günthard, H. F. AU - Opravil, M. AU - Yerly, S. AU - Böni, J. PY - 2011 DA - 2011// TI - Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study JO - HIV Med VL - 12 UR - https://doi.org/10.1111/j.1468-1293.2010.00885.x DO - 10.1111/j.1468-1293.2010.00885.x ID - Young2011 ER - TY - JOUR AU - Vidal, J. E. AU - Song, A. T. AU - Matos, M. L. AU - Bartmann, D. AU - Anjos, G. D. AU - Miranda, É. J. PY - 2013 DA - 2013// TI - High rate of virologic suppression with darunavir/ritonavir plus optimized background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil JO - Braz J Infect Dis VL - 17 UR - https://doi.org/10.1016/j.bjid.2012.08.022 DO - 10.1016/j.bjid.2012.08.022 ID - Vidal2013 ER - TY - JOUR AU - Frentz, D. AU - Boucher, C. A. AU - Assel, M. AU - Luca, A. AU - Fabbiani, M. AU - Incardona, F. PY - 2010 DA - 2010// TI - Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0011505 DO - 10.1371/journal.pone.0011505 ID - Frentz2010 ER - TY - JOUR AU - Cahn, P. AU - Fourie, J. AU - Grinsztejn, B. AU - Hodder, S. AU - Molina, J. M. AU - Ruxrungtham, K. PY - 2011 DA - 2011// TI - Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients JO - AIDS VL - 25 UR - https://doi.org/10.1097/QAD.0b013e328345ee95 DO - 10.1097/QAD.0b013e328345ee95 ID - Cahn2011 ER - TY - JOUR AU - Biscione, F. M. AU - Westin, M. R. AU - Ribeiro, K. M. AU - Estevam, D. L. AU - Cardoso, S. W. AU - Tenore, S. B. PY - 2014 DA - 2014// TI - Virologic and immunologic effectiveness at 48 weeks of darunavir–ritonavir-based regimens in treatment-experienced persons living with HIV-1 infection in clinical practice: a multicenter Brazilian cohort JO - J Int Assoc Provid AIDS Care VL - 13 UR - https://doi.org/10.1177/2325957413502542 DO - 10.1177/2325957413502542 ID - Biscione2014 ER - TY - JOUR AU - Delaugerre, C. AU - Buyck, J. F. AU - Peytavin, G. AU - Viard, J. P. AU - Chaix, M. L. AU - Zucman, D. PY - 2010 DA - 2010// TI - Factors predictive of successful darunavir/ritonavir-based therapy in highly antiretroviral-experienced HIV-1-infected patients (the DARWEST study) JO - J Clin Virol VL - 47 UR - https://doi.org/10.1016/j.jcv.2009.12.022 DO - 10.1016/j.jcv.2009.12.022 ID - Delaugerre2010 ER - TY - JOUR AU - Cooper, D. A. AU - Steigbigel, R. T. AU - Gatell, J. M. AU - Rockstroh, J. K. AU - Katlama, C. AU - Yeni, P. PY - 2008 DA - 2008// TI - Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0708978 DO - 10.1056/NEJMoa0708978 ID - Cooper2008 ER - TY - JOUR AU - Giambenedetto, S. AU - Torti, C. AU - Prosperi, M. AU - Manca, N. AU - Lapadula, G. AU - Paraninfo, G. PY - 2009 DA - 2009// TI - Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study JO - Infection VL - 37 UR - https://doi.org/10.1007/s15010-009-8237-x DO - 10.1007/s15010-009-8237-x ID - Giambenedetto2009 ER - TY - JOUR AU - Ghidei, L. AU - Simone, M. J. AU - Salow, M. J. AU - Zimmerman, K. M. AU - Paquin, A. M. AU - Skarf, L. M. PY - 2013 DA - 2013// TI - Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals JO - Drugs Aging VL - 30 UR - https://doi.org/10.1007/s40266-013-0107-7 DO - 10.1007/s40266-013-0107-7 ID - Ghidei2013 ER -